CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Study of Triapine in Combination With Gemcitabine in Adenocarcinoma of the Biliary Ducts and Gall Bladder

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00075504
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:06.753459+00:00
Published At: 2015-09-28T00:00:00+00:00
Record Updated At: 2015-09-28
Results Posted At: 2015-09-28
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Stage II Gallbladder Cancer", "Stage IIIA Gallbladder Cancer", "Stage IIIB Gallbladder Cancer", "Stage IVA Gallbladder Cancer", "Stage IVB Gallbladder Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2015-09-28"
protocolSection.identificationModule.nctId: "NCT00075504"
protocolSection.identificationModule.officialTitle: "A Phase II Study of Triapine in Combination With Gemcitabine in Adenocarcinoma of the Biliary Ducts and Gall Bladder"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2015-09-28"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.